Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease
- PMID: 36835441
- PMCID: PMC9961468
- DOI: 10.3390/ijms24044029
Novel Molecules in Diabetes Mellitus, Dyslipidemia and Cardiovascular Disease
Abstract
The purpose of this Special Issue is to present the impact in clinical practice as well as in medical research of novel molecules that have been introduced in the treatment of diabetes mellitus, dyslipidaemia, and cardiovascular disease [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Treatment of dyslipidemia in patients with diabetes mellitus.Pharmacol Rep. 2005;57 Suppl:10-9. Pharmacol Rep. 2005. PMID: 16415483 Review.
-
[Diabetes and dyslipidemia: Why are they so closely related?].Vnitr Lek. 2016 Fall;62(11):908-911. Vnitr Lek. 2016. PMID: 28128578 Review. Czech.
-
Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia.Diab Vasc Dis Res. 2019 Jan;16(1):38-46. doi: 10.1177/1479164118805320. Epub 2018 Oct 17. Diab Vasc Dis Res. 2019. PMID: 30328360
-
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.BMC Cardiovasc Disord. 2017 Jun 17;17(1):160. doi: 10.1186/s12872-017-0591-5. BMC Cardiovasc Disord. 2017. PMID: 28623902 Free PMC article.
-
"If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.Cardiovasc Diabetol. 2010 Jun 15;9:24. doi: 10.1186/1475-2840-9-24. Cardiovasc Diabetol. 2010. PMID: 20550659 Free PMC article.
Cited by
-
Achievement of Treatment Goals and Mortality in Individuals with Diabetes: The ELSA-Brasil Study.J Clin Med. 2023 Dec 13;12(24):7663. doi: 10.3390/jcm12247663. J Clin Med. 2023. PMID: 38137733 Free PMC article.
-
Using XGBoost for Predicting In-Stent Restenosis Post-DES Implantation: Role of Lymphocyte-to-Monocyte Ratio and Residual Cholesterol.Int J Gen Med. 2024 Aug 9;17:3443-3452. doi: 10.2147/IJGM.S477053. eCollection 2024. Int J Gen Med. 2024. PMID: 39139709 Free PMC article.
-
Cardiometabolic Risk: Characteristics of the Intestinal Microbiome and the Role of Polyphenols.Int J Mol Sci. 2023 Sep 6;24(18):13757. doi: 10.3390/ijms241813757. Int J Mol Sci. 2023. PMID: 37762062 Free PMC article. Review.
-
The Relationship Between Oxidative Stress, Selenium, and Cumulative Risk in Metabolic Syndrome.In Vivo. 2023 Nov-Dec;37(6):2877-2887. doi: 10.21873/invivo.13406. In Vivo. 2023. PMID: 37905638 Free PMC article.
-
Elucidation of α-glucosidase inhibitory activity and UHPLC-ESI-QTOF-MS based metabolic profiling of endophytic fungi Alternaria alternata BRN05 isolated from seeds of Swietenia macrophylla king.Front Fungal Biol. 2025 Jan 28;6:1447609. doi: 10.3389/ffunb.2025.1447609. eCollection 2025. Front Fungal Biol. 2025. PMID: 39944407 Free PMC article.
References
-
- Zlacká J., Murár M., Addová G., Moravčík R., Boháč A., Zeman M. Synthesis of Glycolysis Inhibitor PFK15 and Its Synergistic Action with an Approved Multikinase Antiangiogenic Drug on Human Endothelial Cell Migration and Proliferation. Int. J. Mol. Sci. 2022;23:14295. doi: 10.3390/ijms232214295. - DOI - PMC - PubMed
-
- Lee D., Tomita Y., Miwa Y., Shinojima A., Ban N., Yamaguchi S., Nishioka K., Negishi K., Yoshino J., Kurihara T. Nicotinamide Mononucleotide Prevents Retinal Dysfunction in a Mouse Model of Retinal Ischemia/Reperfusion Injury. Int. J. Mol. Sci. 2022;23:11228. doi: 10.3390/ijms231911228. - DOI - PMC - PubMed
-
- Lee D., Tomita Y., Miwa Y., Jeong H., Shinojima A., Ban N., Yamaguchi S., Nishioka K., Negishi K., Yoshino J., et al. Nicotinamide Mononucleotide Protects against Retinal Dysfunction in a Murine Model of Carotid Artery Occlusion. Int. J. Mol. Sci. 2022;23:14711. doi: 10.3390/ijms232314711. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical